Skip to main content
SpringerLink
Log in
Book cover

Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen pp 187–206Cite as

Pankreaskarzinom

  • Chapter

  • 57 Accesses

Part of the book series: Molekulare Medizin ((MOLMED))

Zusammenfassung

Das Pankreaskarzinom, das 1936 durch Mondier zum 1. Mal beschrieben wurde, steht in Deutschland sowohl bei der Frau als auch beim Mann in der Sterbestatistik an 6. Stelle. 1997 starben in Deutschland 11319 Personen an dieser Erkrankung (Statistisches Bundesamt 1999). Trotz intensivster Anstrengungen überleben das 1. Jahr nach der Diagnosestellung auch heute nur < 20% der Patienten und die 5-J ahres-überlebensrate beträgt < 5%, weshalb sich für diese Tumorart die Mortalitätszahlen praktisch nicht von den Inzidenzwerten abheben. Darüber hinaus nimmt die Inzidenz dieses Tumors in Deutschland kontinuierlich zu, eine Tendenz, die sich auch in vielen anderen Ländern findet. Inwieweit diese Zunahme auf eine verbesserte und intensivierte Diagnostik zurückzuführen ist, kann nur schwer geklärt werden.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Attisano L, Wrana JL (2000) Smads as transcriptional comodulators. Curr Opin Cell Biol 12:235–243

    PubMed  CAS  Google Scholar 

  • Bansal P, Sonnenberg A (1995) Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology 109:247–251

    PubMed  CAS  Google Scholar 

  • Bartsch D, Skevlin DW, Tung WS, Visker O, Wills SA, Goodfellow PJ (1995) Frequent mutations of CDKN2 in primary pancreatic carcinomas. Genes Chromosomes Cancer 14:189–195

    PubMed  CAS  Google Scholar 

  • Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK (1996) A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Cancer Res 56:3409–3414

    PubMed  CAS  Google Scholar 

  • Berthelemy P, Bouisson M, Escourrou J, Vaysse N, Rumeau JL, Pradayrol L (1995) Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 123:188–191

    PubMed  CAS  Google Scholar 

  • Bishop JM (1987) The molecular genetics of cancer. Science 235:305–311

    PubMed  CAS  Google Scholar 

  • Boschman CR, Stryker S, Reddy J, Rao MS (1994) Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. Am J PathoL 145:1291–1295

    PubMed Central  PubMed  CAS  Google Scholar 

  • Brennan JA, Mao L, Hruban RH et al. (1995) Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332:429–435

    PubMed  CAS  Google Scholar 

  • Brentnall TA, Chen R, Lee JG et al. (1995) Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55:4264–4267

    PubMed  CAS  Google Scholar 

  • Caca K, Kolligs FT, Ji X et al. (1999) Beta-and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ 10:369–376

    PubMed  CAS  Google Scholar 

  • Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE (1994a) Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 54:3568–3573

    PubMed  CAS  Google Scholar 

  • Caldas C, Hahn SA, Costa da LT et al. (1994b) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8:27–32

    PubMed  CAS  Google Scholar 

  • Calle EE, Murphy TK, Rodriguez C, Thun MI, Heath CJ (1998) Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control 9:403–410

    PubMed  CAS  Google Scholar 

  • Cheng JQ, Ruggeri B, Klein WM et al. (1996) Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci USA 93:3636–3641

    PubMed Central  PubMed  CAS  Google Scholar 

  • Couch FI, Farid LM, DeShano ML et al. (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13:123–125

    PubMed  CAS  Google Scholar 

  • Cubilla AL, Fitzgerald PJ (1976) Morphologicallesions associated with human primary invasive carcinoma nonendocrine pancreas cancer. Cancer Res 36:2690–2698

    PubMed  CAS  Google Scholar 

  • Dai JL, Turnacioglu KK, Schutte M, Sugar AY, Kern SE (1998) Dpc4 transcriptional activation and dysfunction in cancer cells. Cancer Res 58:4592–4597

    PubMed  CAS  Google Scholar 

  • Derynck R, Zhang Y, Feng X-H (1998) Smads: transcriptional activators of TGF-ß responses. Cell 95:737–740

    PubMed  CAS  Google Scholar 

  • DiGuiseppe JA, Hruban RH, Offerhaus GJ et al. (1994a) Detection of K-ras mutation in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 144:889–895

    Google Scholar 

  • DiGiuseppe JA, Hruban RH, Goodman SN et al. (1994b) Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 101:684–688

    PubMed  CAS  Google Scholar 

  • Doll R, Peto R (1976) Mortality in relation to smoking: 20 years’ observation on male British doctors. BMJ 2:1525–1536

    PubMed Central  PubMed  CAS  Google Scholar 

  • El-Deiry WS, Tokino T, Velculescu VE et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825

    PubMed  CAS  Google Scholar 

  • El-Deiry WS, Harper JW, O’Connor PM et al. (1994) WAF1/CIP1 is induced in p53-mediated GI arrest and apoptosis. Cancer Res 54:1169–1174

    PubMed  CAS  Google Scholar 

  • Eppert K, Scherer SW, Ozcelik H et al. (1996) MADR2 maps to 18q21 and encodes a TGF-ß-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543–552

    PubMed  CAS  Google Scholar 

  • Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. JAMA 273:1605–1609

    PubMed  CAS  Google Scholar 

  • Feig LA (1993) Strategies for suppressing the function of oncogenic Ras protein in tumors. J Natl Cancer Inst 85:1266–1268

    PubMed  CAS  Google Scholar 

  • Ferbus D, Flechon A, Muleris M et al. (1999) Amplification and over-expression of OZF, a gene encoding a zinc finger protein, in human pancreatic carcinomas. Int J Cancer 80:369–372

    PubMed  CAS  Google Scholar 

  • Friedl W, Kruse R, Uhlhaas S et al. (1999) Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients. Genes Chromosomes Cancer 25:403–406

    PubMed  CAS  Google Scholar 

  • Fukushige S, Furukawa T, Satoh K et al. (1998) Loss of chromosome 18q is an early event in pancreatic ductal tumorigenesis. Cancer Res 58:4222–4226

    PubMed  CAS  Google Scholar 

  • Furuya N, Kawa S, Akamatsu T, Furihata K (1997) Longterm follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology 113:593–598

    PubMed  CAS  Google Scholar 

  • Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283:2552–2558

    PubMed  CAS  Google Scholar 

  • Giardiello FM, Welsh SB, Hamilton SR et al. (1987) Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316:1511–1414

    PubMed  CAS  Google Scholar 

  • Giardiello FM, Brensinger JD, Tersmette AC et al. (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119:1447–1453

    PubMed  CAS  Google Scholar 

  • Goggins M, Schutte M, Lu J et al. (1996) Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56:5360–5364

    PubMed  CAS  Google Scholar 

  • Goggins M, Offerhaus GJ, Hilgers W. et al. (1998a) Pancreatic adenocarcinomas with DNA replication errors (RER +) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 152:1501–1507

    PubMed Central  PubMed  CAS  Google Scholar 

  • Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE (1998b) Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 58:5329–5332

    PubMed  CAS  Google Scholar 

  • Goldstein AM, Fraser MC, Struewing JP et al. (1995) Increased risk of pancreatic cancer in melanoma-prone kindreds with p16 INK4 mutations. N Engl J Med 333:970–974

    PubMed  CAS  Google Scholar 

  • Gruis NA, Sandkuijl LA, van der Velden PA et al. (1995) CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families. Melanoma Res 5:169–177

    PubMed  CAS  Google Scholar 

  • Grünewald K, Lyons J, Fröhlich A et al. (1989) High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 43:1037–1041

    PubMed  Google Scholar 

  • Gullo L (1999) Diabetes and the risk of pancreatic cancer. Ann Oncol [Suppl] 10:79–81

    PubMed  Google Scholar 

  • Hahn SA, Seymour AB, Hoque ATMS et al. (1995) Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 55:4670–4675

    PubMed  CAS  Google Scholar 

  • Hahn SA, Hoque ATM, Moskaluk CA et al. (1996a) Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 56:490–494

    PubMed  CAS  Google Scholar 

  • Hahn SA, Schutte M, Hoque ATM et al. (1996b) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350–353

    PubMed  CAS  Google Scholar 

  • Hahn SA, Bartsch D, Schroers A et al. (1998) Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res 58:1124–1126

    PubMed  CAS  Google Scholar 

  • Hara M, Akasaka K, Akinaga S et al. (1993) Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc Natl Acad Sci USA 90:2281–2285

    PubMed Central  PubMed  CAS  Google Scholar 

  • Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 cdk-interacting protein Cipl is a potent inhibitor of GI cyclin-dependent kinases. Cell 75:805–816

    PubMed  CAS  Google Scholar 

  • Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318–1327

    PubMed  CAS  Google Scholar 

  • Hayashi N, Ito I, Yanagisawa A et al. (1995) Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 345:1257–1259

    PubMed  CAS  Google Scholar 

  • Heinmöller E, Dietmaier W, Zirngibl H et al. (2000) Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol 157:83–92

    PubMed Central  PubMed  Google Scholar 

  • Heldin C-H, Miyazono K, Dijke P ten (1997) TGF-ß signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465–471

    PubMed  CAS  Google Scholar 

  • Hemminki A, Markie D, Tomlinson I et al. (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391:184–187

    PubMed  CAS  Google Scholar 

  • Hiyama E, Kodama T, Shinbara K et al. (1997) Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 57:326–331

    PubMed  CAS  Google Scholar 

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49–53

    PubMed  CAS  Google Scholar 

  • Howe GR, Jain M, Burch JD et al. (1991) Cigarette smoking and cancer of the pancreas: evidence from a population-based control study in Toronto, Canada. Int J Cancer 47:323–328

    PubMed  CAS  Google Scholar 

  • Howe JR, Roth S, Ringold JC et al. (1998) Mutations in the smad4/dpc4 gene in juvenile polyposis. Science 280: 1086–1088

    PubMed  CAS  Google Scholar 

  • Hruban RH, Mansfeld ADM. van, Offerhaus GJ et al. (1993) K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 143:545–554

    PubMed Central  PubMed  CAS  Google Scholar 

  • Hruban RH, Adsay NV, Albores-Saavedra J et al. (2001) Pancreatic intraepithelial neoplasia (PanIN): a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol, in press

    Google Scholar 

  • Huang L, Goodrow TL, Zhang S-Y, Klein-Szanto AJP, Chang H, Ruggeri BA (1996) Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinoma. Cancer Res 56:1137–1141

    PubMed  CAS  Google Scholar 

  • Huntsman DG, Chin SF, Muleris M et al. (1999) MLL2, the second human homolog of the Drosophila tri thorax gene, maps to 19q13.1 and is amplified in solid tumor cell lines. Oncogene 18:7975–7984

    PubMed  CAS  Google Scholar 

  • James GL, Goldstein JL, Brown MS et al. (1993) Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science 260:1937–1942

    PubMed  CAS  Google Scholar 

  • Jenne DE, Reimann H, Nezu J et al. (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38–43

    PubMed  CAS  Google Scholar 

  • Johnson K, Kirkpatrick H, Corner A, Hoffmann FM, Laughon A (1999) Interaction of Smad complexes with tri-partite DNA-binding sites. J Biol Chem 274:20709–20716

    PubMed  CAS  Google Scholar 

  • Jones JB, Kern SE (2000) Functional mapping of the MHI DNA-binding domain of DPC4/SMAD4. Nucleic Acids Res 28:2363–2368

    PubMed Central  PubMed  CAS  Google Scholar 

  • Kahn SM, Jiang W, Culbertson TA et al. (1991) Rapid and sensitive nonradioactive detection of mutant K-ras genes via’ enriched’ PCR amplification. Oncogene 6:1079–1083

    PubMed  CAS  Google Scholar 

  • Kalthoff H, Schmiegel W, Roeder C et al. (1993) p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene8:289–298

    PubMed  CAS  Google Scholar 

  • Karlson B-M, Ekbom A, Josefsson S, McLaughlin JK, Fraumeni JF, Nyren O (1997) The risk of pancreatic cancer following pancreatitis: an association due to confounding? Gastroenterology 113:587–592

    PubMed  CAS  Google Scholar 

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304–6311

    PubMed  CAS  Google Scholar 

  • Kim NW, Piatyszek MA, Prowse KR et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015

    PubMed  CAS  Google Scholar 

  • Kim SK, Fan Y, Papadimitrakopoulou V et al. (1996) DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res 56:2519–2521

    PubMed  CAS  Google Scholar 

  • Kingsley DM (1994) The TGF-ß superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133–146

    PubMed  CAS  Google Scholar 

  • Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH (1996) World Health Organization international histological classification of tumors, 2nd edn. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Knudson JAG (1985) Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45:1437–1443

    PubMed  CAS  Google Scholar 

  • Kohl NE, Mosser SD, de Solms SJ et al. (1993) Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260:1934–1937

    PubMed  CAS  Google Scholar 

  • Kondo H, Sugano K, Fukayama N et al. (1994) Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 73:1589–1594

    PubMed  CAS  Google Scholar 

  • Kozuka S, Sassa R, Takai T et al. (1979) Relation of pancreatic duct hyperplasia to carcinoma. Cancer 43:1418–1428

    PubMed  CAS  Google Scholar 

  • Lagna G, Hata A, Hemmati BA, Massague J (1996) Partnership between DPC4 and SMAD proteins in TGF-ß signalling pathways. Nature 383:832–836

    PubMed  CAS  Google Scholar 

  • Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340:685–689

    PubMed  CAS  Google Scholar 

  • Longnecker DS (1994) The quest for preneoplastic lesions in the pancreas. Arch Pathol Lab Med 118:226

    PubMed  CAS  Google Scholar 

  • Lowenfels AB, Maisonneuve P, Cavallini G et al. (1993) Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328:1433–1437

    PubMed  CAS  Google Scholar 

  • Lowenfels AB, Maisonneuve P, DiMagno EP et al. (1997) Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89:442–446

    Google Scholar 

  • Lüttges J, Möllmann B, Menke MAOH et al. (1999) Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch 435:461–468

    PubMed  Google Scholar 

  • Lüttges J, Diederichs A, Menke MAOH, Vogel I, Kremer B, Klöppel G (2000) Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nudear immunoreactivity for p53. Cancer 88:2495–2504

    PubMed  Google Scholar 

  • Lüttges J, Galehdari H, Bröcker V et al. (2001) Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic careinogenesis. Am J Pathol in press

    Google Scholar 

  • Lynch HT, Fusaro RM (1991) Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. Pancreas 6:127–131

    PubMed  CAS  Google Scholar 

  • Massague J (1992) Receptors for the TGF-ß family. Cell 69: 1069–1070

    Google Scholar 

  • McKie AB, Filipe MI, Lemoine NR (1993) Abnormalities affecting the APC and MCC tumour suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer. Int J Cancer 55:598–603

    PubMed  CAS  Google Scholar 

  • Miyaki M, Iijima T, Konishi M et al. (1999) Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18:3098–3103

    PubMed  CAS  Google Scholar 

  • Mizumoto K, Suehara N, Muta T et al. (1996) Semi-quantitative analysis of telomerase in pancreatic ductal adenocarcinoma. J Gastroenterol 31:894–897

    PubMed  CAS  Google Scholar 

  • Morin PJ, Sparks AB, Korinek V et al. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790

    PubMed  CAS  Google Scholar 

  • Moskaluk CA, Hruban RH, Lietman A et al. (1997a) Novel germline p16(INK4) allele (Asp145Cys) in a family with multiple pancreatic carcinomas. Hum Mutat 12:70–77

    Google Scholar 

  • Moskaluk CA, Hruban RH, Kern SE (1997b) p16 and K-ras mutations in the intraductal precursors of human pancreaticadenocarcinoma. Cancer Res 57:2140–2143

    PubMed  CAS  Google Scholar 

  • Nagasu T, Yoshimatsu K, Rowell C, Lewis MD, Garcia AM (1995) Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956. Cancer Res 55:5310–5314

    PubMed  CAS  Google Scholar 

  • Nagatake M, Takagi Y, Osada H et al. (1996) Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 56:2718–2720

    PubMed  CAS  Google Scholar 

  • Naumann M, Savitkaia N, Eilert C, Schramm A, Kalthoff H, Schmiegel W (1996) Frequent codeletions of p16/MTS1 and p1S/TS2 and genetic alterations in p16/MTS1 in pancreatic tumors. Gastroenterology 110:1215–1224

    PubMed  CAS  Google Scholar 

  • Pantel K, Izbicki J, Passlick B et al. (1996) Frequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small lung cancer without overt metastasis. Lancet 347:649–653

    PubMed  CAS  Google Scholar 

  • Pellegata NS, Sessa F, Renault B et al. (1994) K-ras and pS3 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 54:1556–1560

    PubMed  CAS  Google Scholar 

  • Peters M, Herskowitz I (1994) Joining the complex: cydindependent kinase inhibitory proteins and the cell cycle. Cell 79:181–184

    Google Scholar 

  • Phelan CM, Lancaster JM, Tonin P et al. (1996) Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet 13:120–122

    PubMed  CAS  Google Scholar 

  • Polyak K, Lee M-H, Erdjument-Bromage H et al. (1994) Cloning of p27Kip1 a cydin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66

    PubMed  CAS  Google Scholar 

  • Raftery LA, Twombly V, Wharton K, Gelbart WM (1996) Genetic screens to identify elements of the decapentaplegic signaling pathway in drosophila. Genetics 139:241–254

    Google Scholar 

  • Redston MS, Caldas C, Seymour AB et al. (1994) p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 54:3025–3033

    PubMed  CAS  Google Scholar 

  • Riggins GJ, Kinzier KW, Vogelstein B, Thiagalingam S (1997) Frequency of Smad gene mutations in human cancer. Cancer Res 57:2578–2580

    PubMed  CAS  Google Scholar 

  • Roder JD, Thorban S, Pantel K, Siewert JR (1999) Micrometastases in bone marrow: prognostic indicators for pancreatic cancer. World J Surg 23:888–891

    PubMed  CAS  Google Scholar 

  • Rozenblum E, Schutte M, Goggins M et al. (1997) Tumorsuppressive pathways in pancreatic carcinoma. Cancer Res 57:1731–1734

    PubMed  CAS  Google Scholar 

  • Ruggeri BA, Huang L, Wood M, Cheng JQ, Testa JR (1998) Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Mol Carcinog 21:81–86

    PubMed  CAS  Google Scholar 

  • Rustgi AK (1996) MAD about colorectal cancer. Gastroenterology 111:1387–1389

    PubMed  CAS  Google Scholar 

  • Savage C, Das P, Finelli AL, Townsend SR, Sun C.Y., Baird SE (1996) Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor ß pathway components. Proc Natl Acad Sci USA 93:790–794

    PubMed Central  PubMed  CAS  Google Scholar 

  • Schutte M, Hruban RH, Hedrick L et al. (1996) DPC4 gene in various tumor types. Cancer Res 56:2527–2530

    PubMed  CAS  Google Scholar 

  • Schutte M, Hruban RH, Geradts J et al. (1997) Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 57:3126–3130

    PubMed  CAS  Google Scholar 

  • Schwarte-Waldhoff I, Klein S, Blass-Kampmann S et al. (1999) DPC4/SMA4 mediated tumor suppression of colorectal carcinoma is associated with reduced urokinase expression. Oncogene 18:3152–3158

    PubMed  CAS  Google Scholar 

  • Schwarte-Waldhoff I, Volpert OV, Bouck NP et al. (2000) Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci USA 97: 9624–9629

    PubMed Central  PubMed  CAS  Google Scholar 

  • Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM (1995) Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139:1347–1358

    PubMed Central  PubMed  CAS  Google Scholar 

  • Sepp-Lorenzino L, Ma Z, Rands E et al. (1995) A peptidomimetic inhibitor of farnesyl: protein transferase blocks the anchorage-dependent and independent growth of human tumor cell lines. Cancer Res 55:5302–5309

    PubMed  CAS  Google Scholar 

  • Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cydin D/CDK4. Nature 366:704–707

    PubMed  CAS  Google Scholar 

  • Seymour AB, Hruban RH, Redston M et al. (1994) Allelo-type of pancreatic adenocarcinoma. Cancer Res 54:2761–2764

    PubMed  CAS  Google Scholar 

  • Sherr CJ (1993) Mammalian G1 cyclins. Cell 73:1059–1065

    PubMed  CAS  Google Scholar 

  • Shi Y, Wang Y.F., Jayaraman L, Yang H, Massague J, Pavletich NP (1998) Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell 94:585–594

    PubMed  CAS  Google Scholar 

  • Sidransky D, Tokino T, Hamilton SR et al. (1992) Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256:102–105

    PubMed  CAS  Google Scholar 

  • Silvermann DT, Dunn JA, Hoover RN et al. (1994) Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 86:1510–1516

    Google Scholar 

  • Solinas TS, Wallrapp C, Muller PF, Bentz M, Gress T, Lichter P (1996) Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 56:3803–3807

    Google Scholar 

  • Sparks AB, Morin PJ, Vogelstein B, Kinzier KW (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130–1134

    PubMed  CAS  Google Scholar 

  • Statistisches Bundesamt (1999) Gesundheitswesen. In: Statistisches Bundesamt(Hrsg) Statistisches Jahrbuch 1999. Metzler-Poeschel, Stuttgart, S 424–425

    Google Scholar 

  • Stein GH, Beeson M, Gordon L (1990) Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 249:666–669

    PubMed  CAS  Google Scholar 

  • Strumberg D, Wilke H, Illiger HJ, Klempnauer J (1999) Karzinom des exokrinen Pankreas. In: Schmoll HJ, Höffken K, Possinger K (Hrsg) Kompendium internistischer Onkologie, 3. Aufl. Springer, Berlin Heidelberg New York, S 1111

    Google Scholar 

  • Su GH, Hilgers W, Shekher MC, Tang DJ, Yeo CJ, Hruban RH, Kern SE (1998) Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res 58:2339–2342

    PubMed  CAS  Google Scholar 

  • Su GH, Hruban RH, Bansal RK et al. (1999) Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 154:1835–1840

    PubMed Central  PubMed  CAS  Google Scholar 

  • Suehara N, Mizumoto K, Tanaka M et al. (1997) Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res: 2479–2483

    Google Scholar 

  • Suehara N, Mizumoto K, Kusumoto M et al. (1998) Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer. Am J Gastroenterol 93:1967–1971

    PubMed  CAS  Google Scholar 

  • Sugio K, Molberg K, Albores SJ, Virmani AK, Kishimoto Y, Gazdar AF (1997) K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers. Int J Pancreatol21:205–217

    PubMed  CAS  Google Scholar 

  • Suzuki H, Yoshida S, Ichikawa Y et al. (1994) K-ras mutations in pancreatic secretions and aspirates from two patients without pancreatic cancer. J Natl Cancer Inst 86:1547–1549

    PubMed  CAS  Google Scholar 

  • Tada M, Omata M, Kawai S et al. (1993) Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 53:2472–2474

    PubMed  CAS  Google Scholar 

  • Tada M, Ohashi M, Shiratori Y et al. (1996) Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 110:227–231

    PubMed  CAS  Google Scholar 

  • Takagi Y, Kohmura H, Futamura M et al. (1996) Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 111:1369–1372

    PubMed  CAS  Google Scholar 

  • Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM (1998) Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92:645–656

    PubMed  CAS  Google Scholar 

  • Thiagalingam S, Lengauer C, Leach FS et al. (1996) Evaluation of candidate tumor suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13:342–346

    Google Scholar 

  • Thorlaeius S, Olafsdottir G, Tryggvadottir L et al. (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117–119

    Google Scholar 

  • Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67–74

    PubMed  CAS  Google Scholar 

  • Tulinius H, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Bjarnadottir K (1994) Neoplastic diseases in families of breast cancer patients. J Med Genet 31:618–621

    PubMed Central  PubMed  CAS  Google Scholar 

  • Uehara H, Nakaizumi A, Tatsuta M et al. (1999) Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations. Am J Gastroenterol 94:2513–2518

    PubMed  CAS  Google Scholar 

  • Wallrapp C, Muller PF, Solinas TS et al. (1997) Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Cancer Res 57:3135–3139

    PubMed  CAS  Google Scholar 

  • Warshaw AL, Castillo del CF (1992) Pancreatic carcinoma. N Engl J Med 326:455–465

    PubMed  CAS  Google Scholar 

  • Watanabe H, Sawabu N, Ohta H et al. (1993) Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers. Jpn J Cancer Res 84:961–965

    PubMed  CAS  Google Scholar 

  • Weinberg RA (1989) Oncogenes, antioncogenes, and the molecular basis of multistep carcinogenesis. Cancer Res 49:3713–3721

    PubMed  CAS  Google Scholar 

  • Whelan AJ, Bartsch D, Goodfellow PJ (1995) A familial syndrome of pancreatic carcinoma and melanoma with a mutation in the CDKN2 tumor suppressor gene. N Engl J Med 333:975–977

    PubMed  CAS  Google Scholar 

  • Whitcomb DC, Gorry MC, Preston RA et al. (1996) Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14:141–145

    PubMed  CAS  Google Scholar 

  • Wilentz RE, Hruban RH (1998) Pathology of cancer of the pancreas. Surg Oncol Clin N Am 7:43–65

    PubMed  CAS  Google Scholar 

  • Wilentz RE, Geradts J, Maynard R et al. (1998) Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 58:4740–4744

    PubMed  CAS  Google Scholar 

  • Wilentz RE, Goggins M, Redston M et al. (2000a) Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity. Am J Pathol 156:1641–1651

    PubMed Central  PubMed  CAS  Google Scholar 

  • Wilentz RE, Iacobuzio DC, Argani P et al. (2000b) Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60:2002–2006

    PubMed  CAS  Google Scholar 

  • Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366:701–704

    PubMed  CAS  Google Scholar 

  • Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T (2000) Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 156:2123–2133

    PubMed Central  PubMed  CAS  Google Scholar 

  • Yanagisawa A, Ohtake K, Ohashi K et al. (1993) Frequent cKi-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 53:953–956

    PubMed  CAS  Google Scholar 

  • Zawel L, Dai JL, Buckhaults P et al. (1998) Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1:611–617

    PubMed  CAS  Google Scholar 

  • Zhou S, Buckhaults P, Zawel L et al. (1998) Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. Proc Natl Acad Sci USA 95:2412–2416

    PubMed Central  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Stephan A. Hahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolff Schmiegel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Max-Delbrück-Centrum für Molekulare Medizin (MDC), Robert-Rössle-Str.10, 13122, Berlin-Buch, Germany

    Detlev Ganten  & Klaus Ruckpaul  & 

  2. Medizinische Universitätsklinik Knappschaftskrankenhaus, In der Schornau 23-25, 44892, Bochum-Langendreer, Germany

    Stephan A. Hahn  & Wolff Schmiegel  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hahn, S.A., Schmiegel, W. (2002). Pankreaskarzinom. In: Ganten, D., Ruckpaul, K., Hahn, S.A., Schmiegel, W. (eds) Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen. Molekulare Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56297-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56297-6_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62572-5

  • Online ISBN: 978-3-642-56297-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation